Life Science, Biotech & Manufacturing
Beacon Capital and group of family offices have continued to invest in noble therapies in the areas of oncology, orphan drugs, and neurodegenerative disease. We believe in the importance of preventative medicine. and applying a common-sense approach to personalized medicine.
Our footprint has been predominantly Middle East, North America, and Latin America. We have built relationships with local players to leverage their national market expertise in generics and biologics. Our entry into the pharmaceutical manufacturing arena stems from over a decade of experience in biotech and life sciences investment. Our long-term hold investment strategy evolves from our social impact model to transform and accelerate pharmaceutical discovery. and provide access to therapeutics worldwide.
Beacon Pharmaceutical envisages developing the Beacon Center for Life Science and Research a private-public partnership with the town of Jupiter, Florida. A continuation in the efforts to develop Palm Beach County as a beacon for the Life Science initiatives which has brought Max Planck Institute and Scripps Research Institute to Jupiter, Florida. Jupiter is the "Home to Life Sciences" and a leading epicenter for research, pharmaceutical manufacturing, and cutting edge scientific innovation. The Beacon Center for Life Science and Research is anticipated opening will take place in February 2021.
The Beacon Pharmaceutical Initiative will finance life science companies globally and create a home for these companies in the Sunny State. of Florida.
45 Rockefeller Plaza. Suite 2000
New York, NY. 10111
2000 PGA Blvd. Suite 4440
Palm Beach, Fl. 33408
For any general inquiries, please fill in the following contact form: